Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in ...
The US Pet Supplement Market was valued at US$ 895.91 million in 2023 and is projected to surpass a valuation of US$ 1,475.50 million by 2032 at a CAGR of 5.7% during the forecast period 2024–2032.